## Abstract Paired serum and saliva specimens were collected on a regular basis from 18 asymptomatic blood donors participating in a controlled clinical trial of interferon alpha 2a (IFN) treatment of chronic hepatitis C virus (HCV) infection. Nine patients were randomised to receive interferon and
The gold standard serologic marker for hepatitis B virus infectivity
β Scribed by Leonard B. Seeff
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 331 KB
- Volume
- 8
- Category
- Article
- ISSN
- 0270-9139
No coin nor oath required. For personal study only.
β¦ Synopsis
We invite any of the readers of Hepatology to nominate noteworthy papers published elsewhere and Elsewhereol-EDITOR, "HEPATOLOGY Elsewhere" ogists (themselves or others) to prepare Elsewheres about them.
π SIMILAR VOLUMES
The sequence encoding the truncated core protein (amino acids 1-98) of hepatitis C virus (HCc) was expressed in E. coli for production of HCc (1-98) , or fused with the truncated core antigen (HBcAg) and segments from the preS1 and preS2 regions from hepatitis B virus (HBV) for production of HBcPreS
## Abstract A seroepidemiological study was carried out in three different institutions for the aged. Serological evidence of HBV infection and the HBsAg carrier rate were found to be significantly increased in all three institutions with respect to the control group (noninstitutionalized aged). Of
The expression of the preSl antigen of hepatitis B virus in sera from chronic HBsAg carriers was studied using a specific monoclonal antibody F35.25 in an original, double-immunoradiometric assay. The antibody F35.25 recognized an epitope located between amino-acid residues 32 and 53 on the preSl se